NYSE:HCP - HCP Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$31.02 -0.59 (-1.87 %)
(As of 05/21/2019 04:26 AM ET)
Previous Close$31.61
Today's Range$30.86 - $31.74
52-Week Range$22.49 - $32.23
Volume1.78 million shs
Average Volume3.09 million shs
Market Capitalization$14.83 billion
P/E Ratio17.04
Dividend Yield4.68%
Beta0.43
HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Receive HCP News and Ratings via Email

Sign-up to receive the latest news and ratings for HCP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustrySpecialized REITs
SectorFinance
CUSIP40414L10
Phone949-407-0700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.85 billion
Cash Flow$3.3828 per share
Book Value$13.39 per share

Profitability

Net Income$1.06 billion

Miscellaneous

Employees201
Market Cap$14.83 billion
Next Earnings Date8/1/2019 (Estimated)
OptionableOptionable

HCP (NYSE:HCP) Frequently Asked Questions

What is HCP's stock symbol?

HCP trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCP."

How often does HCP pay dividends? What is the dividend yield for HCP?

HCP declared a quarterly dividend on Thursday, April 25th. Shareholders of record on Monday, May 6th will be paid a dividend of $0.37 per share on Tuesday, May 21st. This represents a $1.48 dividend on an annualized basis and a yield of 4.77%. The ex-dividend date of this dividend is Friday, May 3rd. View HCP's Dividend History.

How were HCP's earnings last quarter?

HCP, Inc. (NYSE:HCP) posted its earnings results on Wednesday, May, 1st. The real estate investment trust reported $0.44 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.43 by $0.01. The real estate investment trust had revenue of $436.15 million for the quarter, compared to analysts' expectations of $442.20 million. HCP had a return on equity of 18.05% and a net margin of 59.96%. The company's revenue for the quarter was down 9.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.48 EPS. View HCP's Earnings History.

When is HCP's next earnings date?

HCP is scheduled to release their next quarterly earnings announcement on Thursday, August 1st 2019. View Earnings Estimates for HCP.

What guidance has HCP issued on next quarter's earnings?

HCP updated its FY19 earnings guidance on Wednesday, May, 1st. The company provided earnings per share guidance of $1.70-1.76 for the period, compared to the Thomson Reuters consensus estimate of $1.73.

What price target have analysts set for HCP?

13 brokerages have issued twelve-month target prices for HCP's shares. Their predictions range from $24.00 to $33.00. On average, they anticipate HCP's share price to reach $28.95 in the next twelve months. This suggests that the stock has a possible downside of 6.7%. View Analyst Price Targets for HCP.

What is the consensus analysts' recommendation for HCP?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HCP in the last year. There are currently 1 sell rating, 4 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for HCP.

What are Wall Street analysts saying about HCP stock?

Here are some recent quotes from research analysts about HCP stock:
  • 1. According to Zacks Investment Research, "Shares of HCP have outperformed the industry it belongs to over the past three months. However, the trend in estimate revisions for 2019 funds from operations (FFO) per share does not indicate a favorable outlook for the company.  Notably, HCP remains on track to execute portfolio-repositioning measures in a bid to improve the quality of the senior housing portfolio and lower operator concentration. Further, focus to strengthen its balance sheet by using sale proceeds to repay debt also bodes well. Also, investments in medical office and life science real estate properties are expected to drive long-term growth. Yet, the dilutive impact on earnings in the near term from asset disposals is unavoidable. Further, the choppy senior housing fundamentals and elevated supply in some of the company’s markets will drag HCP’s results." (3/14/2019)
  • 2. Cantor Fitzgerald analysts commented, "We are initiating coverage of HCP with a $28 price target and a Neutral rating. HCP has risen by 16% over the past three months, along with other large-cap REITs, but it is down 17.5% over the past year, compared with a 14% gain in the 12% decline in the S&P U.S. Healthcare REIT Index. We believe that most of the stock’s relative weakness reflects concern about interest rates, deteriorating fundamentals in senior housing and HCP’s restructuring. With HCP’s restructuring nearly at an end, we expect investors to begin valuing the company more on its fundamentals, which we expect to improve, and to worry less about interest rates. Although we think senior housing could remain slow for awhile, we are enthusiastic about HCP’s strategy to leverage its position in life science and MOB." (8/7/2018)

Has HCP been receiving favorable news coverage?

Headlines about HCP stock have trended somewhat negative this week, InfoTrie reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. HCP earned a news sentiment score of -1.3 on InfoTrie's scale. They also gave news coverage about the real estate investment trust a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Who are some of HCP's key competitors?

What other stocks do shareholders of HCP own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HCP investors own include AT&T (T), Welltower (WELL), Omega Healthcare Investors (OHI), Realty Income (O), Verizon Communications (VZ), General Electric (GE), Cisco Systems (CSCO), Intel (INTC), Kinder Morgan (KMI) and Gilead Sciences (GILD).

Who are HCP's key executives?

HCP's management team includes the folowing people:
  • Mr. Thomas M. Herzog, Pres, CEO & Director (Age 56)
  • Mr. Peter A. Scott, Exec. VP & CFO (Age 39)
  • Mr. Thomas M. Klaritch, Exec. VP, COO & Chief Devel. Officer (Age 61)
  • Mr. Scott M. Brinker, Exec. VP & Chief Investment Officer (Age 42)
  • Mr. Troy E. McHenry, Exec. VP, Gen. Counsel & Corp. Sec. (Age 46)

Who are HCP's major shareholders?

HCP's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.78%), JPMorgan Chase & Co. (2.39%), Northern Trust Corp (1.79%), PGGM Investments (1.77%), Geode Capital Management LLC (1.75%) and Goldman Sachs Group Inc. (1.59%). Company insiders that own HCP stock include Christine Garvey, Kendall K Young, R Kent Griffin Jr and Thomas Klaritch. View Institutional Ownership Trends for HCP.

Which institutional investors are selling HCP stock?

HCP stock was sold by a variety of institutional investors in the last quarter, including Daiwa Securities Group Inc., Zimmer Partners LP, Renaissance Technologies LLC, Centersquare Investment Management LLC, Centersquare Investment Management LLC, Morgan Stanley, Teachers Insurance & Annuity Association of America and PGGM Investments. Company insiders that have sold HCP company stock in the last year include Christine Garvey and Thomas Klaritch. View Insider Buying and Selling for HCP.

Which institutional investors are buying HCP stock?

HCP stock was bought by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Duff & Phelps Investment Management Co., Resolution Capital Ltd, OppenheimerFunds Inc., Principal Financial Group Inc., SG Americas Securities LLC, Goldman Sachs Group Inc. and Northern Trust Corp. Company insiders that have bought HCP stock in the last two years include Kendall K Young and R Kent Griffin Jr. View Insider Buying and Selling for HCP.

How do I buy shares of HCP?

Shares of HCP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is HCP's stock price today?

One share of HCP stock can currently be purchased for approximately $31.02.

How big of a company is HCP?

HCP has a market capitalization of $14.83 billion and generates $1.85 billion in revenue each year. The real estate investment trust earns $1.06 billion in net income (profit) each year or $1.82 on an earnings per share basis. HCP employs 201 workers across the globe.

What is HCP's official website?

The official website for HCP is http://www.hcpi.com.

How can I contact HCP?

HCP's mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The real estate investment trust can be reached via phone at 949-407-0700 or via email at [email protected]


MarketBeat Community Rating for HCP (NYSE HCP)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  380 (Vote Outperform)
Underperform Votes:  716 (Vote Underperform)
Total Votes:  1,096
MarketBeat's community ratings are surveys of what our community members think about HCP and other stocks. Vote "Outperform" if you believe HCP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/21/2019 by MarketBeat.com Staff

Featured Article: Candlestick

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel